Financial Year |
March 31 2023 |
Monetary Funds |
735,369,630.13 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
6,178,800.00 |
Accounts Receivable |
275,415,224.91 |
Advances to Suppliers |
276,536,960.61 |
Other Receivables |
43,894,088.60 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
3,008,340.17 |
Dividend Receivable |
-- |
Inventories |
677,474,900.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
925,531.32 |
Other Current Assets |
49,090,653.93 |
Total Current Assets |
2,088,555,394.13 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
36,909,903.01 |
Long-term Equity Investment |
-- |
Investment Properties |
69,573,134.13 |
Fixed Assetes |
1,778,627,110.16 |
Under-construction Projects |
386,100,959.97 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
644,961,024.19 |
R&D expenses |
-- |
Goodwill |
1,116,192.86 |
Long-Term Deferred and Prepaid Expenses |
618,509,561.74 |
Deferred Income Tax Assets |
144,853,018.23 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
6,097,459,536.39 |
Total Assets |
8,186,014,930.52 |
Short-Term Loans |
810,299,555.16 |
Trading Financial liabilities |
-- |
Notes Payable |
333,239,186.95 |
Accounts Payable |
1,011,876,603.48 |
Accounts Received In Advance |
48,912,360.49 |
Employee Compensation Payable |
53,283,724.94 |
Taxes Payable |
41,303,588.31 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
168,217,566.52 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
256,707,842.03 |
Other Current Liabilities |
76,849,260.60 |
Sub-Total of Current Liabilities |
3,549,626,346.93 |
Long-term Loans |
181,324,981.26 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
49,100,511.46 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,717,526,939.48 |
Total Liabilities |
6,267,153,286.41 |
Paid-In Capital(Or Share Stock) |
225,631,280.00 |
Capital Surplus |
311,359,012.71 |
Surplus Reserve |
210,177,499.75 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,382,104,008.19 |
Minority Stockholder's Interest |
-210,410,156.54 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,129,271,800.65 |
Owner's Equity(Stockholder's Equity) |
1,918,861,644.11 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,186,014,930.52 |